Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2013
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery
Haifa Shen, Cristian Rodriguez-Aguayo, Rong Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2021
Editor's Note: Functional Roles of <i>Src</i> and <i>Fgr</i> in Ovarian Carcinoma
Hye-Sun Kim, Hee Dong Han, Guillermo N Armaiz-Pena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2009
Surgical stress promotes tumor growth in ovarian carcinoma
Jeong-Won Lee, Mian M K Shahzad, Yvonne G Lin, et al.
Cancer Research
|
August 18, 2018
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer
Yeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer
Pablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2014
Biologic effects of platelet-derived growth factor receptor α blockade in uterine cancer
Ju-Won Roh, Jie Huang, Wei Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2014
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib
Jie Huang, Wei Hu, Justin Bottsford-Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2021
Editor's Note: Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer
Ju-Won Roh, Jie Huang, Wei Hu, et al.
Cancer Cell
|
July 23, 2013
A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis
Massimo Masiero, Filipa Costa Simões, Hee Dong Han, et al.
Cancer Research
|
May 1, 2010
Sustained small interfering RNA delivery by mesoporous silicon particles
Takemi Tanaka, Lingegowda S Mangala, Pablo E Vivas-Mejia, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2013
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery
Haifa Shen, Cristian Rodriguez-Aguayo, Rong Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2021
Editor's Note: Functional Roles of <i>Src</i> and <i>Fgr</i> in Ovarian Carcinoma
Hye-Sun Kim, Hee Dong Han, Guillermo N Armaiz-Pena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2009
Surgical stress promotes tumor growth in ovarian carcinoma
Jeong-Won Lee, Mian M K Shahzad, Yvonne G Lin, et al.
Cancer Research
|
August 18, 2018
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer
Yeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer
Pablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2014
Biologic effects of platelet-derived growth factor receptor α blockade in uterine cancer
Ju-Won Roh, Jie Huang, Wei Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2014
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib
Jie Huang, Wei Hu, Justin Bottsford-Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2021
Editor's Note: Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer
Ju-Won Roh, Jie Huang, Wei Hu, et al.
Cancer Cell
|
July 23, 2013
A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis
Massimo Masiero, Filipa Costa Simões, Hee Dong Han, et al.
Cancer Research
|
May 1, 2010
Sustained small interfering RNA delivery by mesoporous silicon particles
Takemi Tanaka, Lingegowda S Mangala, Pablo E Vivas-Mejia, et al.
Page
of 12